The Latest
Partner Therapeutics Announces Publication of Results From the eNRGy Trial of Zenocutuzumab in Patients with NRG1+ Cholangiocarcinoma in Journal of Clinical Oncology (JCO)
Partner Therapeutics announced the publication of eNRGy trial results of Zenocutuzumab in NRG1+ cholangiocarcinoma in the Journal of Clinical Oncology.